东星医疗
(301290)
| 流通市值：19.99亿 | | | 总市值：29.37亿 |
| 流通股本：6816.34万 | | | 总股本：1.00亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 183,292,306.61 | 78,186,465.07 | 435,463,080.43 | 316,018,608.17 |
| 营业收入 | 183,292,306.61 | 78,186,465.07 | 435,463,080.43 | 316,018,608.17 |
| 二、营业总成本 | 163,130,797.38 | 72,372,834.27 | 358,927,111.5 | 265,917,172.26 |
| 营业成本 | 97,573,435.14 | 43,469,650.62 | 220,492,163.52 | 161,890,589.14 |
| 税金及附加 | 2,498,396.89 | 1,060,168.71 | 5,179,633.04 | 3,639,239.43 |
| 销售费用 | 22,308,254.63 | 8,190,354.26 | 47,576,239.82 | 35,597,739.13 |
| 管理费用 | 32,249,472.08 | 15,240,570.06 | 65,369,542.32 | 50,851,498.2 |
| 研发费用 | 8,419,735.46 | 4,169,622.11 | 22,433,892.09 | 16,698,408.37 |
| 财务费用 | 81,503.18 | 242,468.51 | -2,124,359.29 | -2,760,302.01 |
| 其中:利息费用 | 518,203.73 | 176,906.96 | 338,527.01 | 197,135.61 |
| 其中:利息收入 | 777,545.4 | 115,402.24 | 2,699,802.9 | 3,226,149.73 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,662,563.62 | 107,681.68 | -7,000,940.2 | -7,315,799.69 |
| 加:投资收益 | 11,144,971.24 | 6,486,358.28 | 36,695,547.36 | 27,765,340.17 |
| 资产处置收益 | -12,070.87 | -356.13 | -83,679.38 | -33,857.52 |
| 资产减值损失(新) | 19,648.12 | -29,647 | -480,308.03 | 330,429.41 |
| 信用减值损失(新) | 1,293,770.04 | 1,018,541.47 | -246,809.35 | -1,408,241.48 |
| 其他收益 | 1,208,559.61 | 904,710.09 | 10,222,971.26 | 9,201,243.22 |
| 四、营业利润 | 36,478,950.99 | 14,300,919.19 | 115,642,750.59 | 78,640,550.02 |
| 加:营业外收入 | 76,262.55 | 18,845.23 | 177,247.22 | 83,145.96 |
| 减:营业外支出 | 646,794.05 | 17,632.78 | 756,936.75 | 710,214.44 |
| 五、利润总额 | 35,908,419.49 | 14,302,131.64 | 115,063,061.06 | 78,013,481.54 |
| 减:所得税费用 | 6,254,071.55 | 2,628,534.54 | 18,171,882.27 | 12,566,902.08 |
| 六、净利润 | 29,654,347.94 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 29,654,347.94 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 30,292,870.97 | 12,063,975.22 | 97,424,753.19 | 65,578,456.4 |
| 少数股东损益 | -638,523.03 | -390,378.12 | -533,574.4 | -131,876.94 |
| 扣除非经常损益后的净利润 | 19,036,505.31 | 6,267,512.03 | 66,459,147.18 | 42,664,465.74 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 0.12 | 0.98 | 0.66 |
| (二)稀释每股收益 | 0.3 | 0.12 | 0.98 | 0.66 |
| 九、综合收益总额 | 29,654,347.94 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 |
| 归属于母公司股东的综合收益总额 | 30,292,870.97 | 12,063,975.22 | 97,424,753.19 | 65,578,456.4 |
| 归属于少数股东的综合收益总额 | -638,523.03 | -390,378.12 | -533,574.4 | -131,876.94 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-15 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |